Mutual Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-2,308
Closed -$409K 693
2020
Q1
$409K Sell
2,308
-78
-3% -$14.7K 0.06% 331
2019
Q4
$456K Buy
2,386
+6
+0.3% +$1.08K 0.05% 360
2019
Q3
$401K Sell
2,380
-199
-8% -$32.4K 0.05% 353
2019
Q2
$432K Buy
2,579
+270
+12% +$37.4K 0.06% 351
2019
Q1
$338K Sell
2,309
-38
-2% -$5.51K 0.05% 347
2018
Q4
$314K Sell
2,347
-9
-0.4% -$1.48K 0.06% 312
2018
Q3
$449K Buy
2,356
+39
+2% +$7.17K 0.07% 297
2018
Q2
$386K Buy
2,317
+709
+44% +$114K 0.09% 281
2018
Q1
$271K Buy
+1,608
New +$270K 0.07% 331

Other funds holding AGN

Mutual Advisors's AGN Position: Q2 2020 in Review

Mutual Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,308 shares — an estimated $409K sold.

Mutual Advisors first reported a position in AGN in Q1 2018 and held it in 9 quarters. The position peaked at $456K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Mutual Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Mutual Advisors sold 2,308 Allergan plc shares in Q2 2020, an estimated $409K.
  • Mutual Advisors first reported a position in Allergan plc in Q1 2018 and held it in 9 quarters.
  • Mutual Advisors's Allergan plc position peaked at $456K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Mutual Advisors's 13F filing for Q2 2020, filed 5 Aug 2020.